Barely Significant
← all excerpts

Role of Glucagon-Like Peptide-1 Receptor Agonists in the Management of Non-Alcoholic Steatohepatitis: A Clinical Review Article.

Cureus · 2021 · PMC8214471 · PMID 34164242

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)
A LEAD-2 sub-study followed up the LEAD trial in the same patient population in which liraglutide 1.8 mg showed a trend toward improving hepatic steatosis versus placebo (liver-to-spleen attenuation ratio: +0.10 vs. 0.00; p = 0.07) [ 26 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.